114 related articles for article (PubMed ID: 26202346)
1. Inhibitory Effect of Apigenin on Pharmacokinetics of Venlafaxine in vivo and in vitro.
Zhan YY; Liang BQ; Gu EM; Hu XX; Lin D; Hu GX; Zheng ZQ
Pharmacology; 2015; 96(3-4):118-23. PubMed ID: 26202346
[TBL] [Abstract][Full Text] [Related]
2. Influence of Zuojin Pill on the Metabolism of Venlafaxine in Vitro and in Rats and Associated Herb-Drug Interaction.
Li Y; Li J; Yan D; Wang Q; Jin J; Tan B; Qiu F
Drug Metab Dispos; 2020 Oct; 48(10):1044-1052. PubMed ID: 32561594
[TBL] [Abstract][Full Text] [Related]
3. Nifedipine Does Not Alter the Pharmacokinetics of Venlafaxine Enantiomers in Healthy Subjects Phenotyped for CYP2D6, CYP2C19, and CYP3A.
Tozatto E; Benzi JRL; Rocha A; Coelho EB; Lanchote VL
J Clin Pharmacol; 2021 Mar; 61(3):319-327. PubMed ID: 32974907
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of silybin on pharmacokinetics of imatinib in vivo and in vitro.
Wang L; Wang Z; Xia MM; Wang YY; Wang HY; Hu GX
Can J Physiol Pharmacol; 2014 Nov; 92(11):961-4. PubMed ID: 25365188
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory Effect of Apigenin on Losartan Metabolism and CYP2C9 Activity in vitro.
Wang Z; Gong Y; Zeng DL; Chen LG; Lin GT; Huang CK; Sun W; Chen MC; Hu GX; Chen RJ
Pharmacology; 2016; 98(3-4):183-9. PubMed ID: 27287328
[TBL] [Abstract][Full Text] [Related]
6. The effect of resveratrol on pharmacokinetics of aripiprazole in vivo and in vitro.
Zhan YY; Liang BQ; Li XY; Gu EM; Dai DP; Cai JP; Hu GX
Xenobiotica; 2016; 46(5):439-44. PubMed ID: 26391142
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant polypharmacy and the potential of pharmacokinetic interactions: Doxepin but not mirtazapine causes clinically relevant changes in venlafaxine metabolism.
Paulzen M; Haen E; Hiemke C; Fay B; Unholzer S; Gründer G; Schoretsanitis G
J Affect Disord; 2018 Feb; 227():506-511. PubMed ID: 29156365
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Effects of Apatinib on the Pharmacokinetics of Venlafaxine and O-desmethylvenlafaxine in SD Male Rats by UPLC-MS/MS.
Bao SS; Wen J; Lin QM; Li YH; Huang YG; Zhou HY; Hu GX
Basic Clin Pharmacol Toxicol; 2018 Dec; 123(6):721-726. PubMed ID: 29964362
[TBL] [Abstract][Full Text] [Related]
9. In Vitro and In Vivo Rat Model Assessments of the Effects of Vonoprazan on the Pharmacokinetics of Venlafaxine.
Chen F; Jiang H; Xu J; Wang S; Meng D; Geng P; Dai D; Zhou Q; Zhou Y
Drug Des Devel Ther; 2020; 14():4815-4824. PubMed ID: 33204067
[TBL] [Abstract][Full Text] [Related]
10.
Zhou H; Yang L; Wang C; Li Z; Ouyang Z; Shan M; Gu J; Wei Y
Drug Metab Dispos; 2019 Dec; 47(12):1425-1432. PubMed ID: 31658948
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of ketoconazole and voriconazole on the pharmacokinetics of carvedilol in rats.
Wang L; Wang S; Chen M; Chen X; Lin Y; Hu X; Huang X; Li X; Hu G
Drug Dev Ind Pharm; 2015; 41(10):1661-6. PubMed ID: 25417773
[TBL] [Abstract][Full Text] [Related]
12. Effect of scutellarin on the metabolism and pharmacokinetics of clopidogrel in rats.
Chen X; Jin J; Chen Y; Peng L; Zhong G; Li J; Bi H; Cai Y; Huang M
Biopharm Drug Dispos; 2015 Jan; 36(1):64-8. PubMed ID: 25256597
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with venlafaxine and carbamazepine in depressive patients not responding to venlafaxine: pharmacokinetic and clinical aspects.
Ciusani E; Zullino DF; Eap CB; Brawand-Amey M; Brocard M; Baumann P
J Psychopharmacol; 2004 Dec; 18(4):559-66. PubMed ID: 15582923
[TBL] [Abstract][Full Text] [Related]
14. Effects of Zuojin Pill (Rhizoma Coptidis and Fructus Evodiae preparation) on the pharmacokinetics and side effects of venlafaxine in humans.
Yan D; Wu M; Hu W; Li Y; Jin J; Yan S; Zhu W; Ye C; Liu J; Liu G; Tan B
Basic Clin Pharmacol Toxicol; 2022 Apr; 130(4):522-530. PubMed ID: 35132786
[TBL] [Abstract][Full Text] [Related]
15. Interactions of pharmacokinetic profile of different parts from Ginkgo biloba extract in rats.
Guan H; Qian D; Ren H; Zhang W; Nie H; Shang E; Duan J
J Ethnopharmacol; 2014 Aug; 155(1):758-68. PubMed ID: 24953034
[TBL] [Abstract][Full Text] [Related]
16. CYP2D6*10 polymorphism and the enantioselective O-desmethylation of S-(+)- and R-(-)-venlafaxine in Japanese psychiatric patients.
Sasaki T; Yasui-Furukori N; Komahashi-Sasaki H; Shinozaki M; Hayashi Y; Kato K; Inoue Y; Tsuchimine S; Watanabe T; Sugawara N; Shimoda K
Basic Clin Pharmacol Toxicol; 2021 May; 128(5):677-685. PubMed ID: 33470005
[TBL] [Abstract][Full Text] [Related]
17. Sustained administration of the antidepressant venlafaxine in rats: pharmacokinetic and pharmacodynamic findings.
Wikell C; Hjorth S; Apelqvist G; Kullingsjö J; Lundmark J; Bergqvist PB; Bengtsson F
Naunyn Schmiedebergs Arch Pharmacol; 2001 Apr; 363(4):448-55. PubMed ID: 11330339
[TBL] [Abstract][Full Text] [Related]
18. Effects of CYP2D6 Genotypes on Venlafaxine Metabolism in Japanese Psychiatric Patients With Depression.
Komahashi-Sasaki H; Yasui-Furukori N; Sasaki T; Shinozaki M; Hayashi Y; Kato K; Inoue Y; Tsuchimine S; Watanabe T; Sugawara N; Shimoda K
Ther Drug Monit; 2021 Oct; 43(5):681-687. PubMed ID: 33306568
[TBL] [Abstract][Full Text] [Related]
19. Clinical drug-drug interactions: focus on venlafaxine.
Magalhães P; Alves G; LLerena A; Falcão A
Drug Metab Pers Ther; 2015 Mar; 30(1):3-17. PubMed ID: 24964257
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant and memory affecting influence of estrogen and venlafaxine in ovariectomized rats.
Nowakowska E; Kus K
Arzneimittelforschung; 2005; 55(3):153-9. PubMed ID: 15819387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
